Education
About Us
Working with TipRanks
Follow Us
Concord Healthcare Group Co., Ltd. Class H (HK:2453)
:2453
2453 Stock Chart & Stats
HK$1.83
-HK$0.24(-2.76%)
At close: 4:00 PM EST
HK$1.83
-HK$0.24(-2.76%)
Day’s Range― - ―
52-Week RangeHK$1.31 - HK$8.96
Previous CloseN/A
Volume2.50M
Average Volume (3M)590.21K
Market Cap
HK$1.40B
Enterprise ValueHK$4.20B
Total Cash (Recent Filing)HK$170.03M
Total Debt (Recent Filing)HK$3.23B
Price to Earnings (P/E)―
Beta0.52
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.26
Shares Outstanding313,874,630
10 Day Avg. Volume440,520
30 Day Avg. Volume590,206
Financial Highlights & Ratios
PEG Ratio-1.56
Price to Book (P/B)4.49
Price to Sales (P/S)19.04
P/FCF Ratio-14.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
R&D FocusA sustained corporate emphasis on R&D supports pipeline development and product differentiation in pharmaceuticals. Over 2-6 months this underpins future revenue opportunities, patentable assets and strengthens competitive positioning versus peers reliant on generics.
Diversified Commercial ChannelsEstablished partnerships and multi-channel sales (hospitals, clinics, pharmacies, potential licensing) provide durable distribution reach and reduce single-channel dependency, supporting steadier product uptake and improved access to institutional contracts over time.
Positive Recent Free Cash FlowA recent improvement to positive free cash flow enhances the company’s ability to fund operations, R&D or deleveraging without immediate external capital. If sustained, FCF gives management strategic flexibility to invest or shore up the balance sheet long term.
Bears Say
Declining Revenue And Persistent LossesOngoing top-line contraction and continued losses indicate structural demand or execution issues, reducing reinvestment capacity and eroding margins. Persisting decline constrains growth and increases reliance on capital markets or asset sales to sustain operations.
High Leverage And Weak Equity BaseA high debt-to-equity ratio and weak equity cushion raise refinancing and interest-service risk, limiting strategic options. Over months this constrains capital allocation, elevates solvency risk in downturns, and can force asset sales or costly funding if cash flow weakens.
Negative Operating Cash Flow And MarginsSustained negative operating cash flow and negative margins undermine the core ability to generate cash from operations, driving dependence on financing. This structural profitability shortfall threatens long-term viability unless margins recover or costs are materially restructured.
Concord Healthcare Group Co., Ltd. Class H News
2453 FAQ
What was Concord Healthcare Group Co., Ltd. Class H’s price range in the past 12 months?
Concord Healthcare Group Co., Ltd. Class H lowest stock price was HK$1.31 and its highest was HK$8.96 in the past 12 months.
What is Concord Healthcare Group Co., Ltd. Class H’s market cap?
Concord Healthcare Group Co., Ltd. Class H’s market cap is HK$1.40B.
When is Concord Healthcare Group Co., Ltd. Class H’s upcoming earnings report date?
Concord Healthcare Group Co., Ltd. Class H’s upcoming earnings report date is Mar 26, 2026 which is in 31 days.
How were Concord Healthcare Group Co., Ltd. Class H’s earnings last quarter?
Concord Healthcare Group Co., Ltd. Class H released its earnings results on Aug 28, 2025. The company reported -HK$0.263 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.263.
Is Concord Healthcare Group Co., Ltd. Class H overvalued?
According to Wall Street analysts Concord Healthcare Group Co., Ltd. Class H’s price is currently Overvalued.
Does Concord Healthcare Group Co., Ltd. Class H pay dividends?
Concord Healthcare Group Co., Ltd. Class H does not currently pay dividends.
What is Concord Healthcare Group Co., Ltd. Class H’s EPS estimate?
Concord Healthcare Group Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Concord Healthcare Group Co., Ltd. Class H have?
Concord Healthcare Group Co., Ltd. Class H has 313,874,630 shares outstanding.
What happened to Concord Healthcare Group Co., Ltd. Class H’s price movement after its last earnings report?
Concord Healthcare Group Co., Ltd. Class H reported an EPS of -HK$0.263 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.626%.
Which hedge fund is a major shareholder of Concord Healthcare Group Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2453
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Concord Healthcare Group Co., Ltd. Class H Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-87.59%
12-Months-Change
Fundamentals
Return on Equity
-25.34%
Trailing 12-Months
Asset Growth
2.89%
Trailing 12-Months
Company Description
Concord Healthcare Group Co., Ltd. Class H
Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and medical institutions in China. It also offers oncology-related services, including sales and installing of medical equipment and software; management and technical support; and operating lease services. The company was incorporated in 2008 and is headquartered in Beijing, China. Concord Healthcare Group Co., Ltd operates as a subsidiary of Shanghai Medstar Financial Leasing Company.
Technical Analysis
New Century Healthcare Holding Co. Ltd.
―
Rici Healthcare Holdings Ltd.
―
Guangdong Kanghua Healthcare Co., Ltd. Class H
―
Hygeia Healthcare Holdings Co., Ltd.
―
UMP Healthcare Holdings Limited
―